American Journal of Clinical Dermatology

, Volume 11, Issue 2, pp 117–122 | Cite as

Gardner Syndrome

Skin Manifestations, Differential Diagnosis and Management
Review Article Gardner Syndrome


Gardner syndrome is a variant of familial adenomatous polyposis (FAP) and results in the manifestation of numerous external and internal symptoms including gastrointestinal polyps, osteomas, tumors, and epidermoid cysts. As such, it is highly recommended that physicians conduct full body examinations to catch the key clinical features of the disease when it is suspected. Stemming from a mutation in the adenomatous polyposis coli (APC) gene, Gardner syndrome shares genetic correlations with the FAP phenotype; as a result, it becomes all the more crucial for physicians to be able to discern Gardner syndrome from other differential diagnoses such as Turcot syndrome, FAP, and other attenuated forms of familial polyposis. Fortunately, Gardner syndrome has characteristic polyps in the colon, osteomas, and also exhibits abnormalities in the retinal epithelium that discern it from others.

Surgery is the most effective method of management for Gardner syndrome; restorative proctocolectomy with ileal pouch anal anastomosis with mucosectomy is the top choice for colonic malignancies, and skin manifestations can be treated through a variety of excisions and therapy depending on location, size, and number of malignancies. Currently, there are no specific screening recommendations for Gardner syndrome, but testing following general screening recommendations for extra-colonic malignancies, genetic counseling, and endoscopy are encouraged.


  1. 1.
    Gardner EJ. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermoid cysts. Am J Hum Genet 1962; 14: 376PubMedGoogle Scholar
  2. 2.
    Ornstein K. Polypsis of the colon in children; two cases, one of which with Gardner’s syndrome; a genetic study. Nord Med 1958 May 29; 59 (22): 751–3PubMedGoogle Scholar
  3. 3.
    Allen K. Gardner syndrome [online]. Available from URL: [Accessed 2006 Nov 27]Google Scholar
  4. 4.
    Leppard B, Bussey HJ. Epidermoid cysts, polyposis coli and Gardner’s syndrome. Br J Surg 1975; 62: 387–93CrossRefPubMedGoogle Scholar
  5. 5.
    Tsao H. Update on familial cancer syndromes and the skin. J Am Acad Dermatol 2000 Jun; 42 (6): 939–69, quiz 970-2CrossRefPubMedGoogle Scholar
  6. 6.
    Urabe K, Xia J, Masuda T, et al. Pilomatricoma-like changes in the epidermoid cysts of Gardner syndrome with an gene mutation. J Dermatol 2004 Mar; 31 (3): 255–7PubMedGoogle Scholar
  7. 7.
    Traboulsi El, Krush AJ, Gardner EJ, et al. Prevalence and importance of pigmented ocular fundus lesions in Gardner’s syndrome. N Engl J Med 1987; 316: 661–7CrossRefPubMedGoogle Scholar
  8. 8.
    Giardiello FM, Brensinger JD, Peterson GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121: 198–213CrossRefPubMedGoogle Scholar
  9. 9.
    Hulsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 1994 Dec; 127 (6 Pt 2): 2061–9CrossRefPubMedGoogle Scholar
  10. 10.
    Lamlum H, Papadopoulou A, Ilyas M, et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci U S A 2000; 97: 2225–8CrossRefPubMedGoogle Scholar
  11. 11.
    Giardiello FM, Krush AJ, Petersen GM, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106: 1542–7PubMedGoogle Scholar
  12. 12.
    Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57 (115): 1–8Google Scholar
  13. 13.
    Wallis YL, Macdonald F, Hulten M, et al. Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 1994; 94: 543–8CrossRefPubMedGoogle Scholar
  14. 14.
    Foulkes W. A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome. Q J Med 1995; 88: 853–63Google Scholar
  15. 15.
    Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006 Feb; 101 (2): 385–98CrossRefPubMedGoogle Scholar
  16. 16.
    Campbell WJ, Spence RAJ, Parks TG. Familial adenomatous polyposis. Br J Surg 1994; 81: 1722–33CrossRefPubMedGoogle Scholar
  17. 17.
    Itoh H, Hirata K, Ohsata K. Turcot’s syndrome and familial adenomatous polyposis associated with brain tumor: a review of related literature. Int J Colorectal Dis 1993; 8: 87–94CrossRefPubMedGoogle Scholar
  18. 18.
    Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP): a review of the literature. Fam Cancer 2003; 2 (1): 43–55CrossRefPubMedGoogle Scholar
  19. 19.
    Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214–8CrossRefPubMedGoogle Scholar
  20. 20.
    Watson P, Lynch HT. The tumor spectrum in HNPCC. Anticancer Res 1994; 14: 1635–9PubMedGoogle Scholar
  21. 21.
    Vasen HFA, Mecklin J-P, Khan PM, et al. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424–5CrossRefPubMedGoogle Scholar
  22. 22.
    Bussey H. Familial polyposis coli: family studies, histopathology, differential diagnosis and results of treatment. Baltimore (MD): Johns Hopkins University Press, 1975Google Scholar
  23. 23.
    Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot’s syndrome. New Engl J Med 1995; 332: 839–47CrossRefPubMedGoogle Scholar
  24. 24.
    Olschwang S, Bonaiti C, Feingold J, et al. HNPCC syndrome (hereditary nonpolyposis colon cancer): identification and management [in French]. Rev Med Interne 2005 Feb; 26 (2): 109–18CrossRefPubMedGoogle Scholar
  25. 25.
    Vasen HFA, Watson P, Mecklin J-P, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453–6CrossRefPubMedGoogle Scholar
  26. 26.
    Singhal H. Gardner syndrome [online]. Available from URL: [Accessed 2006 Dec 25]Google Scholar
  27. 27.
    Nandakumar G, Morgan JA, Silverberg D, et al. Familial polyposis coli: clinical manifestations, evaluation, management and treatment. Mount Sinai J Med 2004 Nov; 71 (6): 384–91Google Scholar
  28. 28.
    Healy JC, Reznek RH, Clark SK, et al. MR appearances of desmoid tumors in familial adenomatous polyposis. AJR Am J Roentgenol 1997; 169: 465PubMedGoogle Scholar
  29. 29.
    Giardello FM, Brensinger MS, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997; 336: 823–7CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  1. 1.Resident PG2 Internal MedicineLos AngelesUSA
  2. 2.Veterans Affairs Medical Center and State University of New York at Downstate, BrooklynBrooklynUSA

Personalised recommendations